Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors

NCT ID: NCT04609228

Last Updated: 2022-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1911 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-30

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to analyze mortality after cardiac surgery in blood-transfusion non-acceptors (BTNA), and the secondary one to perform an adjusted comparison with a blood-transfusion acceptors (BTA) matched cohort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracic Surgery Blood Transfusion; Hemoglobinemia Cardiac Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blood-transfusion non-acceptors

Blood-transfusion non-acceptors

Non-acceptance of blood-transfusions

Intervention Type OTHER

Patients who do not accept blood products transfusions

Blood-transfusion acceptors

Blood-transfusion acceptors

Acceptance of blood-transfusions

Intervention Type OTHER

Patients who accept blood products transfusions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-acceptance of blood-transfusions

Patients who do not accept blood products transfusions

Intervention Type OTHER

Acceptance of blood-transfusions

Patients who accept blood products transfusions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing heart surgery in our hospital from 2009 to June 2020

Exclusion Criteria

* Preoperative hemoglobin lower than 120g/L
* EuroSCORE-II higher than 20%
* Heart transplant
* Assist device implantation
* Surgery of acute myocardial infarction-derived complications
* Other emergent cardiac surgeries (acute aortic dissection, heart injuries).
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elena Roselló-Díez, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Cardiac surgeon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fundació de Gestió Sanitària de l'Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elena Roselló-Díez, MD, PhD

Role: CONTACT

+34 935565957

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elena Roselló-Díez, MD, PhD

Role: primary

+34 935565957

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IIBSP-TRA-2020-36

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.